Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

MSer – A new, neutral descriptor for someone with multiple sclerosis
Clinical spectrum of CNS aquaporin-4 autoimmunity.
ICV-transplanted human glial precursor cells are short-lived yet exert immunomodulatory effects in mice with EAE.
The Safety Profile of Dalfampridine Extended Release in Multiple Sclerosis Clinical Trials.
Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.
Spinal Cord Atrophy and Early Motor Recovery following Transverse Myelitis in Pediatric Patients.
Human Endogenous Retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.
Severe disease reactivation in four patients with relapsing-remitting multiple sclerosis after fingolimod cessation.
Effects of dual-task balance training on postural performance in patients with Multiple Sclerosis: A double-blind, randomized controlled pilot trial.
Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.
Riluzole enhances glutamate uptake in rat astrocyte cultures.
Periventricular Demyelination and Axonal Pathology Is Associated with Subependymal Virus Spread in a Murine Model for Multiple Sclerosis.
Axonal damage in acute multiple sclerosis lesions.
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Presumptive Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis after Natalizumab Therapy.
Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc.
Patient's Perspective: Hard Lessons from a Long Hospital Stay.
Remote effects of intermittent theta burst stimulation of the human pharyngeal motor system.
Analysis of the Paired TCR α- and β-chains of Single Human T Cells.
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis.
Evaluation of olfactory dysfunction in neurodegenerative diseases.
Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses.
The nocebo effect: A clinicians guide.
Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab.
17β-trenbolone, an anabolic-androgenic steroid as well as an environmental hormone, contributes to neurodegeneration.

Pages